Difference between revisions of "LincRNA-CALCA"
(Created page with " ==Annotation== ===Name=== lincRNA-CALCA ===Alias=== NA ===Disease=== Disease: hepatocelluar cancer [http://www.ncbi.nlm.nih.gov/pubmed/25556502 (PMID:25556502)] Dysfunctio...") |
|||
| Line 21: | Line 21: | ||
Description: biomarker | Description: biomarker | ||
| + | |||
| + | |||
| + | ===Function=== | ||
| + | Function Mechanism: transcriptional regulation [http://www.ncbi.nlm.nih.gov/pubmed/23483581 (PMID:23483581)] | ||
| + | |||
| + | Biological Process: pathogenic process | ||
| + | |||
| + | Description: NA | ||
Latest revision as of 07:22, 5 November 2018
Annotation
Name
lincRNA-CALCA
Alias
NA
Disease
Disease: hepatocelluar cancer (PMID:25556502)
Dysfunction type: expression
Description: The most upregulated lncRNAs in H2 were RP11-672F9.1, RP5-1014O16.1, and RP11-501G6.1, while the most downregulated ones were lincRNA-TSPAN8, lincRNA-CALCA, C14orf132, NCRNA00173, and CR613944. A large number of lncRNAs may play important roles in driving HCC cells to metastasize to different sites; these lncRNAs may provide novel molecular biomarkers and offer a new basis for combating metastasis in HCC cases.
Function
Function Mechanism: NA (PMID:25556502)
Biological Process: pathogenic process
Description: biomarker
Function
Function Mechanism: transcriptional regulation (PMID:23483581)
Biological Process: pathogenic process
Description: NA
